📊 RMHI Key Takeaways
Is RMHI a Good Investment? Thesis Analysis
RMHI exhibits critical insolvency with negative stockholders equity of -$603.4K and zero revenue generation. The company is depleting its minimal cash reserves with negative operating cash flows while incurring persistent operating losses, indicating operational collapse. Severely outdated financial data (Dec 2022) prevents current assessment and combined with balance sheet insolvency suggests extreme distress.
Why Buy RMHI? Key Strengths
- Minimal cash reserves of $96.7K provide limited operational runway
- No long-term debt obligations reported
- Low total asset base limits downside exposure to creditors
RMHI Investment Risks to Consider
- Negative stockholders equity of -$603.4K indicates technical insolvency and bankruptcy risk
- Zero revenue with negative operating cash flow of -$30.9K demonstrates no viable business operations
- Financial data from December 2022 is extremely outdated, preventing accurate current assessment and potential delisting risk
Key Metrics to Watch
- Current stockholders equity and solvency status
- Cash burn rate and months of runway remaining
- Any evidence of revenue generation or operational activity resumption
RMHI Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
RMHI Profitability Ratios
RMHI vs Healthcare Sector
How Retrieve Medical Holdings, Inc. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is RMHI Overvalued or Undervalued?
Based on fundamental analysis, Retrieve Medical Holdings, Inc. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
RMHI Balance Sheet & Liquidity
RMHI 5-Year Financial Trend & Growth Analysis
5-Year Trend Summary: Retrieve Medical Holdings, Inc.'s revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.00 indicates the company is currently unprofitable.
RMHI Growth Metrics (YoY)
RMHI Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2017 | N/A | $9.8K | N/A |
| Q2 2017 | N/A | -$5.5K | N/A |
| Q1 2017 | N/A | -$1.9K | N/A |
| Q3 2016 | N/A | -$9.8K | N/A |
| Q2 2016 | N/A | -$590.1K | N/A |
| Q3 2015 | $178.8K | -$488.5K | N/A |
| Q2 2015 | $149.6K | -$320.5K | N/A |
| Q1 2015 | $117.4K | -$525.6K | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
RMHI Capital Allocation
RMHI SEC 10-K & 10-Q Filing Analysis
Access official SEC EDGAR filings for Retrieve Medical Holdings, Inc. (CIK: 0001452804)
📋 Recent SEC Filings
❓ Frequently Asked Questions about RMHI
What is the AI rating for RMHI?
Retrieve Medical Holdings, Inc. (RMHI) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are RMHI's key strengths?
Claude: Minimal cash reserves of $96.7K provide limited operational runway. No long-term debt obligations reported.
What are the risks of investing in RMHI?
Claude: Negative stockholders equity of -$603.4K indicates technical insolvency and bankruptcy risk. Zero revenue with negative operating cash flow of -$30.9K demonstrates no viable business operations.
What is RMHI's revenue and growth?
Retrieve Medical Holdings, Inc. reported revenue of $0.0.
Does RMHI pay dividends?
Retrieve Medical Holdings, Inc. does not currently pay dividends.
Where can I find RMHI SEC filings?
Official SEC filings for Retrieve Medical Holdings, Inc. (CIK: 0001452804) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RMHI's EPS?
Retrieve Medical Holdings, Inc. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is RMHI a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Retrieve Medical Holdings, Inc. has a STRONG SELL rating with 95% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is RMHI stock overvalued or undervalued?
Valuation metrics for RMHI: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
Should I buy RMHI stock in 2026?
Our dual AI analysis gives Retrieve Medical Holdings, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RMHI's free cash flow?
Retrieve Medical Holdings, Inc.'s operating cash flow is $-30.9K, with capital expenditures of $0.0.
How does RMHI compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio 0.00 (avg: 2).